Boyd Street Ventures Invests in HealthTech Innovator Watkins-Conti
News release announcing BSV investment in innovative women's healthcare firm
News release announcing BSV investment in innovative women's healthcare firm
News release announcing BSV investment in VinSense
News release announcing a breakthrough opportunity for grant-making institutions
News release announcing anchor investment by OGE Energy Corp. Foundation
Boyd Street Ventures news release announcing selection of James Spann as a member of the 2024 EY Entrepreneurs Access Network Cohort
News release announcing of new BSV Venture Studio Manager.
Biotech firm aims to halt the progression of multiple sclerosis.
Innovator reduces blindness risk through a relationship-driven, intelligent eye care management platform.
Company addresses problem affecting millions of colonoscopies annually.
Read the November 2023 Newsletter from the Boyd Street Ventures team.
Exum is a scientific instrumentation company with innovative technology that significantly shortens development and discovery time for new materials,...
Firm is developing novel intranasal and oral vaccines based on SC-AdVax platform licensed from the Mayo Clinic.
We created the Boyd Street Endowment Fund to support businesses led by minorities, females and socially and economically disadvantaged individuals (SEDI).